Topical Steroid Withdrawal Diagnostic Criteria Defined by NIH Researchers - Criteria May Help Guide Treatment of Dermatitis ...

The report looks at how California and other states can improve PET thermoform circularity through innovation, policy alignment and industry commitments.

Recently reported positive preliminary data from Phase 1 dose escalation trial of micvotabart pelidotin ("MICVO," formerly PYX-201), including a confirmed 50% objective response rate by RECIST 1.1 ...